Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1999-4-7
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0271-0749
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
19
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
101-3
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:9934953-Antipsychotic Agents,
pubmed-meshheading:9934953-Female,
pubmed-meshheading:9934953-Humans,
pubmed-meshheading:9934953-Huntington Disease,
pubmed-meshheading:9934953-Male,
pubmed-meshheading:9934953-Middle Aged,
pubmed-meshheading:9934953-Risperidone,
pubmed-meshheading:9934953-Treatment Outcome
|
pubmed:year |
1999
|
pubmed:articleTitle |
Effectiveness of risperidone in Huntington chorea patients.
|
pubmed:publicationType |
Letter,
Clinical Trial
|